Buprenorphine Tablet
Product Images NDC 50268-129

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 50268-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 (128 15)

Label for Buprenorphine Sublingual Tablets 2 mg by AvPAK. The label shows the strength as 2 mg per tablet and the package contains 50 tablets (5 blister cards of 10 tablets each). It is marked Rx Only and includes storage instructions and a note for pharmacists to dispense a Medication Guide. The label also features barcodes, the NDC 50268-128-15, and AvPAK branding.*

FDA Label Image

50 (129 15)

Label for Buprenorphine Sublingual Tablets 8 mg, prescription only, with a quantity of 50 tablets (5 blister packs of 10 unit doses). The label includes the NDC 50268-129-15, directions for pharmacists, storage conditions, and manufacturer information for AvPAK in Pulaski, Tennessee.*

FDA Label Image

Buprenorphine-figure (Buprenorphine Figure)

Illustration showing a person placing a sublingual tablet under the tongue. The image highlights correct administration of a sublingual tablet by positioning it beneath the tongue for absorption.*

FDA Label Image

Buprenorphine-str (Buprenorphine Str)

Chemical structure diagram of Buprenorphine hydrochloride, showing molecular bonds and functional groups including hydroxyl, methoxy, and cyclopropylmethyl substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.